Lipid accumulation product better predicts metabolic status in lean polycystic ovary syndrome than that by visceral adiposity index
Author:
Publisher
Medknow
Subject
Reproductive Medicine
Reference32 articles.
1. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome.A community-based study from the Southwest of Iran?;Rashidi;Eur J Obstet Gynecol Reprod Biol,2014
2. Metabolic risk in PCOS: Phenotype and adiposity impact;Moran;Trends Endocrinol Metab,2015
3. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: A retrospective, observational study;Morgan;J Clin Endocrinol Metab,2012
4. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis;Moran;Hum Reprod Update,2010
5. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health – National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation;Shaw;J Clin Endocrinol Metab,2008
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipid accumulation product is an effective predictor of metabolic syndrome in non-obese women with polycystic ovary syndrome;Frontiers in Endocrinology;2024-01-10
2. Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study;Journal of Human Reproductive Sciences;2024-01
3. Lipid accumulation product and visceral adiposity index for incidence of cardiovascular diseases and mortality; results from 13 years follow‐up in Isfahan cohort study;Obesity Science & Practice;2023-10-02
4. The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome;Life;2023-09-25
5. Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease;Frontiers in Endocrinology;2023-04-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3